Serotonin syndrome associated with the administration of duloxetine; report of a case

Serotonin syndrome associated with the administration of duloxetine; report of a case

Saved in:

Bibliographic Details
Main Authors:	Ramón Fernández Fernández, Edgar Fernández Alonso, Pedro Castro Rebollo, Dolors Soy Muner
Format:	Article
Language:	English
Published:	Elsevier 2016-05-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/10438.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
by: Novick D, et al.
Published: (2016-02-01)

Treatment of Fibromyalgia - duloxetine or pregabalin?
by: Magdalena Bujak, et al.
Published: (2025-04-01)

External validation of population pharmacokinetic models for meropenem in critically ill adult patients
by: Carla Bastida, et al.
Published: (2025-06-01)

Cidofovir dosage in a critically ill patient undergoing continuous veno-venous hemodiafiltration
by: H. Anglada Martínez, et al.
Published: (2014-01-01)

Transient Serotonin Syndrome by Concurrent Use of Electroconvulsive Therapy and Selective Serotonin Reuptake Inhibitor: A Case Report and Review of the Literature
by: Nagahisa Okamoto, et al.
Published: (2012-01-01)

Linezolid and serotonin syndrome
by: Haytham A. Wali
Published: (2025-02-01)

An Unusual Case of Serotonin Syndrome with Oxycodone and Citalopram
by: Clare Walter, et al.
Published: (2012-01-01)

Duloxetine‐induced syndrome of inappropriate antidiuretic hormone secretion in a patient with neuropathic pain
by: Nobuyuki Takahashi, et al.
Published: (2024-11-01)

Use of dual action inhibitor (duloxetine) in diabetic neuropathy
by: Irina Vladimirovna Gur'eva
Published: (2009-03-01)

Duloxetine-Induced Sleep Bruxism and Tooth Fracture in Fibromyalgia
by: İsmail Tunçekin, et al.
Published: (2024-12-01)

Comparing the effectiveness of pregabalin and duloxetine in the management of neuropathic pain
by: Rojgar Hamed Ali, et al.
Published: (2025-04-01)

Venlafaxine-induced serotonin syndrome causing bilateral cerebral strokes: a case report
by: Nils Mein, et al.
Published: (2025-01-01)

Serotonin Syndrome Induced Tako-Tsubo Syndrome
by: Ian Lancaster, et al.
Published: (2022-01-01)

Self-Limited Kleptomania Symptoms as a Side Effect of Duloxetine
by: Christopher W. T. Miller, et al.
Published: (2016-01-01)

Clinical Relevance of Pharmacogenetics in Serotonin Syndrome
by: Dehuti Pandya, et al.
Published: (2020-01-01)

Psychological and autonomous nervous system features of functional gastric dyspepsia and irritable bowel syndrome, duloxetine treatment efficacy
by: A. P. Pogromov, et al.
Published: (2012-06-01)

Simple UV Spectrophotometric Determination of Duloxetine Hydrochloride in Bulk and in Pharmaceutical Formulations
by: Mohammad Yunoos, et al.
Published: (2010-01-01)

Serotonin Syndrome Associated With High-dose Diphenhydramine Use Complicating Abdominoplasty and Mastopexy
by: Ashley E. Rosenberg, BS, et al.
Published: (2025-03-01)

Serotonin Syndrome Triggered by Ondansetron in Organophosphorus Poisoning Presenting as a Dual Clinical Challenge: A Case Report
by: Karra Keerthi Reddy, et al.
Published: (2025-08-01)

Efficacy of Duloxetine for Postspine Surgery Pain: A Systematic Review and Meta‐Analysis
by: Abdulsalam Mohammed Aleid, et al.
Published: (2025-01-01)

WCN24-285 THE ROLE OF VASOPRESSIN-2 RECEPTOR IN DULOXETINE-INDUCED HYPONATREMIA
by: Gheun-Ho Kim, et al.
Published: (2024-04-01)

Serotonin Syndrome in the Setting of Lamotrigine, Aripiprazole, and Cocaine Use
by: Anupam Kotwal, et al.
Published: (2015-01-01)

Dextromethorphan-induced serotonin syndrome leading to rhabdomyolysis and dialysis-requiring acute kidney injury: a case report and review
by: Kazuhiro Okamoto, et al.
Published: (2025-04-01)

Enhancing Duloxetine With Mirogabalin for Treating Taxane-Induced Peripheral Neuropathy in Advanced Lung Cancer
by: Yasuhiro Nakajima MD, PhD, et al.
Published: (2025-06-01)

Duloxetine-Induced Hyponatremia in an Elderly Male Patient with Treatment-Refractory Major Depressive Disorder
by: Ching-Fang Sun, et al.
Published: (2019-01-01)

An Unexpected Presentation of Serotonin Syndrome in a Patient Receiving ECT
by: Shahzaib Khan, et al.
Published: (2024-01-01)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
by: Harada E, et al.
Published: (2016-01-01)

Efficacy of duloxetine in treating temporomandibular joint disorder: a systematic review with bayesian meta-analysis
by: Sasidharan Sivakumar, et al.
Published: (2025-08-01)

A comparative study of the effectiveness and safety of pregabalin and duloxetine in the treatment of chemotherapy-induced neuropathic pain
by: Yogendra Singhal, et al.
Published: (2025-01-01)

Delving into the Perception, Use, and Context of Duloxetine in Clinical Practice: An Analysis Based on the Experience of Healthcare Professionals
by: Oscar Fraile-Martinez, et al.
Published: (2025-07-01)

Association of polymorphic variants of serotonin receptor genes, serotonin synthesis and metabolism enzymes genes with depressive disorder and clinical remission
by: N. M. Vyalova, et al.
Published: (2019-12-01)

Serotonin dysfunction in ADHD
by: Eleanor F. Jackson, et al.
Published: (2025-04-01)

Does early improvement in depressive symptoms predict subsequent remission in patients with depression who are treated with duloxetine?
by: Sueki A, et al.
Published: (2016-05-01)

Effect of Ritanserin and Duloxetine on the Gene Expression of Primary Aniridia and Healthy Human Limbal Stromal Cells, In Vitro
by: Zhen Li, et al.
Published: (2024-09-01)

Selective Serotonin Reuptake Inhibitors and Risk of Gastrointesinal Bleeding In Dyspepsia: An Evidence-Based Case Report
by: Hamzah Shatri, et al.
Published: (2023-11-01)

The eco-friendly spectrophotometric methods for duloxetine and amitriptyline quantification using eosin Y: content uniformity and greenness evaluation
by: Al Amir S. Zaafan, et al.
Published: (2025-03-01)

Immunomodulatory Effects Mediated by Serotonin
by: Rodrigo Arreola, et al.
Published: (2015-01-01)

Novel spectrophotometric methods for concurrent assessment of duloxetine and avanafil in their binary mixture using derivative spectroscopy: greenness-blueness evaluation
by: Hadeer A. Elhamdy, et al.
Published: (2025-04-01)

DREAM: an adaptive, randomised, placebo-controlled trial of duloxetine for reducing leg pain in people with chronic sciatica—trial protocol
by: Martin Underwood, et al.
Published: (2024-12-01)

Development and validation of derivative UV spectroscopic methods for simultaneous estimation of duloxetine and tadalafil in their binary mixtures: greenness-blueness evaluation
by: Dalia M. Nagy, et al.
Published: (2025-05-01)